G-PUR® for Reduced Lead Bioavailability

NCT04138693 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Lead Exposure

Interventions

DEVICE: G-PUR® 2x 2.0 g oral suspension
DEVICE: G-PUR® 1x 2.0 g oral suspension
DEVICE: Placebo oral suspension

Sponsor

Glock Health, Science and Research GmbH